Health Innovation 2030, €650 million for eHealth!



At the 2021 Strategic Council for Health Industries (CSIS), on 29 June 2021, the President of France presented the Health Innovation 2030 plan. Its ambition is to make France the leading European nation in terms of health.

The Health Innovation 2030 plan and the eHealth acceleration strategy

A proactive project is being implemented with the mobilisation of €7 billion, including €650 million for eHealth as part of the French recovery plan and Future Investments Programme. This strategy is based on 5P medicine: Preventive, personalised, predictive, participatory and pragmatic (i.e. Evidence-based).
Indeed, the French health system is facing major challenges like the ageing of the population, the development of chronic diseases, and scattered resources, requiring reforms to the dated cost-effectiveness model.

France, a leader in the eHealth sector

France must position itself as a world leader in the eHealth sector It needs to catch up, due to a lack of investment in digital infrastructure, the complexity of systems created in silos, a lack of acceptability and trust in digital technology by both the general public and professionals, a lack of insight into market access, and a shortage of training for health professionals and engineers in health issues.

Several major complementary public programs have already been launched in eHealth and a real dynamic has been created:
• the roadmap for eHealth and the digital Ségur reforms, supported by the Ministry of Health, which aims to modernise, secure and facilitate data exchanges between health professionals and with the patient
• the Paris Santé Campus program, which aims to create a coherent and synergistic group of public and private operators, with the ambition of constructing an eHealth research and innovation sector that is global in reach
• the Health Data Hub which helps accelerate research and innovation based on health data

The eHealth Acceleration Strategy

The actions supported by this eHealth Acceleration Strategy aim to encourage the emergence of innovative solutions, based on multidisciplinary scientific approaches and ambitious cost-effectiveness models, to conquer the eHealth market, which is growing rapidly worldwide.
The design of the strategy is based on the results of a broad public consultation (429 responses) and targeted interviews (46 interviews) that allowed the ecosystem to express its expectations and priorities. This feedback has clarified and prioritised the content of the acceleration strategy, and is helping to design future calls for projects.

The strategy is broken down into 5 priority areas represented in chronological order of a project's life:

1, Développer la formation, la confiance des acteurs et l'attractivité professionnelle du secteur. 2, Préparer la future génération des technologies clés en santé numérique et faciliter le transfert rapide des résultats de recherche. 3, Soutenir la maturation des projets structurants et renforcer l'avantage stratégique (données, IA, sécurité). 4, Accompagner la mise en œuvre d'expérimentations en vie réelle et la conduite de premières étapes industrielles. 5, Favoriser les conditions de la réussite d'un déploiement à grande échelle.

Examples of 5 shining achievements of the strategy:

1. In the 'Training' area, eHealth modules were launched in initial training courses for jobs in the health and social care sector by all occupational training operators. Thus, 210,000 students will be trained in eHealth in 24 courses and 36 universities.

2. In the 'Maturation' area, support was provided for the development of a top-flight imaging sector in France, by stepping up the co-financing effort for the development of new medical imaging solutions and image processing software.

3. In the 'Trials' axis, support was provided for the evaluation of the medical and/or economic added value of software medical devices by financing approximately 50 projects by 2025. 4. In the 'Trials' area, support was provided for the emergence of third-party trial sites for digital technology in healthcare organisations. Thus, 30 third-party sites will be opened in order to implement trials under real conditions and to carry out the first stages of mass release. 5. In the 'Deployment' axis, discussion was launched on implementing expanded access to digital medical devices, in order to facilitate access to their market.

Find out more